Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2NBP

Solution structure of the T119M variant of transthyretin in its monomeric state

Summary for 2NBP
Entry DOI10.2210/pdb2nbp/pdb
Related2NBO
NMR InformationBMRB: 25987
DescriptorTransthyretin (1 entity in total)
Functional Keywordstransthyretin, amyloid, aggregation, monomer, transport protein
Biological sourceHomo sapiens (human)
Cellular locationSecreted: P02766
Total number of polymer chains1
Total formula weight13809.51
Authors
Kim, J.,Oroz, J.,Zweckstetter, M. (deposition date: 2016-03-09, release date: 2017-05-10, Last modification date: 2024-05-15)
Primary citationKim, J.H.,Oroz, J.,Zweckstetter, M.
Structure of Monomeric Transthyretin Carrying the Clinically Important T119M Mutation.
Angew. Chem. Int. Ed. Engl., 55:16168-16171, 2016
Cited by
PubMed Abstract: Mutations in the protein transthyretin can cause as well as protect individuals from transthyretin amyloidosis, an incurable fatal inherited disease. Little is known, however, about the structural basis of pathogenic and clinically protective transthyretin mutants. Here we determined the solution structure of a transthyretin monomer that carries the clinically important T119M mutation. The structure displays a non-native arrangement that is distinct from all known structures of transthyretin and highlights the importance of high-resolution studies in solution for understanding molecular processes that lead to amyloid diseases.
PubMed: 27885756
DOI: 10.1002/anie.201608516
PDB entries with the same primary citation
Experimental method
SOLUTION NMR
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon